Success Metrics

Clinical Success Rate

94.7%

Based on 71 completed trials

Completion Rate

95%(71/75)

Active Trials

11(9%)

Results Posted

30%(21 trials)

Terminated

4(3%)

Phase Distribution

Ph not_applicable

68%

Ph early_phase_1

Ph phase_3

Ph phase_4

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution91 total trials

Early Phase 1First-in-human

1(1.1%)

Phase 3Large-scale testing

2(2.2%)

Phase 4Post-market surveillance

4(4.4%)

N/ANon-phased studies

84(92.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

89.9%

71 of 79 finished

Non-Completion Rate

10.1%

8 ended early

Currently Active

trials recruiting

Total Trials

123

all time

Status Distribution

Active(19)

Completed(71)

Terminated(8)

Other(25)

Detailed Status

Completed71

unknown24

Recruiting8

Not yet recruiting7

Terminated4

Withdrawn4

Development Timeline

Analytics

Development Status

Total Trials

123

Active

Success Rate

94.7%

Most Advanced

Phase 4

Trials by Phase

Early Phase 11 (1.1%)

Phase 32 (2.2%)

Phase 44 (4.4%)

N/A84 (92.3%)

Trials by Status

terminated43%

unknown2420%

enrolling_by_invitation11%

active_not_recruiting32%

not_yet_recruiting76%

recruiting87%

completed7158%

suspended11%

withdrawn43%

Recent Activity

11 active trials

Showing 5 of 123

not_yet_recruiting

The Impact of Surgical Procedures on Postoperative Outcomes in Cataract Phacoemulsification and Analysis of Related Factors

NCT07550907

completednot_applicable

Clinical Trials (123)

Showing 20 of 123 trialsScroll for more

NCT07550907

The Impact of Surgical Procedures on Postoperative Outcomes in Cataract Phacoemulsification and Analysis of Related Factors

Not Yet Recruiting

NCT05646004Not Applicable

621 Real World Study

Completed

NCT07484191Not Applicable

Contralateral Claims Study of Clareon Vivity Pro

Not Yet Recruiting

NCT06401551Not Applicable

Clareon PanOptix Pro vs. Clareon PanOptix - Study B

Completed

NCT05317728Not Applicable

Clinical Study of a Fluid Accommodating Intraocular Lens (IOL) Design

Active Not Recruiting

NCT05985304Not Applicable

Clinical Trial of a Hydrophilic EMV Toric Lens RAO210T in the Correction of Aphakia and Corneal Astigmatism

Completed

NCT06990074Not Applicable

An Early Feasibility, Prospective, Single-Arm Study of the Polaris System

Recruiting

NCT06264232Not Applicable

AT ELANA 841P Posterior Chamber Intraocular Lens for Correction of Aphakia Following Cataract Removal

Completed

NCT06400745Not Applicable

Clareon PanOptix Pro vs. Clareon PanOptix - Study A

Completed

NCT06285695Not Applicable

Clareon Toric Study (T2-T9)

Active Not Recruiting

NCT07135570

"My Eyes, My Light": Amar Chokh, Amar Alo

Recruiting

NCT07070492Not Applicable

Outcomes of Combined Cataract Surgery With Retinal Surgery for Visually Significant Epiretinal Membrane With Vivity Versus Monofocal Intraocular Lens

Not Yet Recruiting

NCT07007897

Observational Study - TA- 2025-1

Enrolling By Invitation

NCT05035394Not Applicable

Swedish Microinvasive Glaucoma Surgery Study (SMIGS)

Active Not Recruiting

NCT04553523Not Applicable

Hydrus® Microstent New Enrollment Post-Approval Study

Recruiting

NCT05564091Not Applicable

Cataract Surgery in Conjunction With Ab-interno Canaloplasty Compared to Cataract Surgery Only in Patients With Mild to Moderate Primary Open-Angle Glaucoma

Recruiting

NCT06924944

Clinical Outcomes of Bilateral Clareon Vivity in Post-Refractive Patients

Recruiting

NCT06658119Not Applicable

Clinical Evaluation of Extended Depth-of-focus Intraocular Lens in Refractive Cataract Surgery: a Randomized Controlled Trial

Recruiting

NCT05955846Not Applicable

Evaluation of Safety and Effectiveness of an IOL With a Virtual Aperture Optic

Not Yet Recruiting

NCT06708806Not Applicable

Cell Ongrowth and Biocompatibility Study of Two Different (Hydrophobic Acrylic) Intraocular Lenses: IOL XY1 vs. IOL XY1A

Completed

Drug Details

Intervention Type: PROCEDURE
Total Trials: 123